Komori
Olympus (7733) · RiskMitigated

Funding Cost and Financial Market Volatility Risk

First written in FY2017. 5 of 11 entries say "Mitigated", first in FY2018. Latest entry: FY2025-H1.

11entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017MitigatedFY2018 – FY2025-H12017: 120172018: 120182019: 120192020: 320202021: 120212022: 220222023: 120232024: 12024
Same theme, other companies
Risk of higher financing costs due to financial market instability and rising interest ratesA theme 74 companies write about · 75 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2023: 9 of 38 companies on the "Worse" side.

12 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 74 companies compared. The sentences above are computed from all 74.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1MitigatedAnnual report

    「Bonds and borrowings decreased by ¥54,134 million as a result of repayments of borrowings, while other current liabilities decreased by ¥36,988 million, mainly because of a decrease in accrued expenses.」

    Reduced bonds and borrowings by ¥54,134 million through repayment of borrowings, thereby reducing funding exposure.
  2. FY2024-Q1MitigatedAnnual report

    「Among current assets, cash and cash equivalents increased by ¥389,393 million, mainly because consideration for the transfer of the Scientific Solutions Business was received.」

    Cash and cash equivalents increased upon receipt of consideration for the transfer of the Scientific Solutions Business, bringing the quarter-end balance to ¥558,722 million. Funding liquidity was substantially strengthened.
  3. FY2022AdvancedAnnual report

    「During the current consolidated fiscal year, we raised USD 500 million through the issuance of foreign-currency-denominated bonds to secure on-hand liquidity and diversify funding sources. The issuance took place in December 2021.」

    Diversified funding sources by issuing USD 500 million of straight bonds denominated in US dollars in December 2021.
  4. FY2022-Q3AdvancedAnnual report

    「During the third quarter of the current consolidated cumulative period, to diversify funding sources, we issued USD 500 million of straight bonds denominated in US dollars for business funding, bearing interest at 2.143% and maturing on 8 December 2026.」

    Diversified funding sources in response to funding risks by issuing USD 500 million of straight bonds denominated in US dollars.
  5. FY2021AdvancedAnnual report

    「As of the end of the current consolidated fiscal year, we held more than ¥200,000 million in cash on hand, an increase of approximately ¥55,000 million from the end of the previous consolidated fiscal year. We believe this level of cash on hand is sufficient to ensure stable business operations and a sound financial base.」

    Secured more than ¥200,000 million in cash on hand through borrowings and bond issuance, an increase of approximately ¥55,000 million from the end of the previous fiscal year.
  6. FY2021-Q2AdvancedAnnual report

    「During the second quarter of the current consolidated cumulative period, in view of the impact of the COVID-19 pandemic on performance, we issued ¥25,000 million of the 26th unsecured corporate bonds, bearing interest at 0.25% and maturing on 18 July 2025, and ¥25,000 million of the 27th unsecured corporate bonds, bearing interest at 0.47% and maturing on 19 July 2030, for business funding and long-term working capital.」

    Issued ¥50,000 million of unsecured corporate bonds to address funding risks associated with COVID-19 and secure long-term liquidity.
  7. FY2021-Q1AdvancedAnnual report

    「During the first quarter of the current consolidated cumulative period, in view of the impact of the COVID-19 pandemic on performance, we obtained borrowings for business funding and long-term working capital of ¥50,000 million, at a fixed borrowing rate of 0.32% with a repayment date of 30 April 2025; ¥40,000 million, at a floating borrowing rate based on TIBOR plus a spread with a repayment date of 31 May 2024; and ¥10,000 million, at a floating borrowing rate based on TIBOR plus a spread with a repayment date of 15 May 2024.」

    To prepare for the impact of COVID-19 on performance, drew down borrowings of ¥50,000 million, ¥40,000 million and ¥10,000 million to secure on-hand liquidity.
  8. FY2020MitigatedAnnual report

    「In preparation for the possibility that the impact of the COVID-19 pandemic could be prolonged, we have also focused on further strengthening on-hand liquidity. Since April 2020, in addition to flexibly raising short-term funds through commercial paper issuance, we have raised ¥100,000 million in medium- to long-term funds through borrowings, securing ample cash on hand.」

    Strengthened on-hand liquidity in response to funding risks through short-term commercial paper and ¥100,000 million in medium- to long-term borrowings.
  9. FY2019MitigatedAnnual report

    「Bonds and borrowings decreased from ¥247,974 million at the end of the previous consolidated fiscal year to ¥181,335 million at the end of the current consolidated fiscal year.」

    Significantly reduced outstanding bonds and borrowings, while continuing to address funding risks through predominantly fixed-rate financing.
  10. FY2018MitigatedAnnual report

    「Long-term funds for investment in equipment and other assets are generally raised through fixed-rate long-term borrowings or bonds. As of 31 March 2018, long-term borrowings totaled ¥213,031 million, including amounts due for repayment within one year, and bonds totaled ¥34,942 million, including amounts due for redemption within one year. Most funding was at fixed rates.」

    Describes the use of predominantly fixed-rate funding for long-term funds as a response to funding costs and interest-rate fluctuations.
  11. FY2017First statedAnnual report

    「Our Group raises funds through borrowings from financial institutions and other sources. Changes in financial market conditions could affect our Group's ability to raise funds. In addition, if funding costs rise because of deteriorating performance or other factors, this could adversely affect our Group's financing.」

    Describes as new risks changes in financial market conditions affecting funding through borrowings and bonds, and higher funding costs resulting from deteriorating performance.
Moved together

"Restructuring the Business Portfolio and Optimizing the Allocation of Management Resources" moved the same way as this thread, in the same document, in 8 of its 11 moves.

877766★123456
  1. ★This thread
  2. 1Restructuring the Business Portfolio and Optimizing the Allocation of Management Resources8×
  3. 2Further expansion of operations centered on the healthcare business7×
  4. 3Maintaining Competitiveness in Gastrointestinal Endoscopy and Growing the Treatment Device and Surgical Businesses7×
  5. 4Active Investment in the Medical Business and Expansion of Growth Areas7×
  6. 5Establishment of a Company-Wide Quality Management System6×
  7. 6Sharing Value with Shareholders Through Performance-Linked Compensation6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Olympus yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Funding Cost and Financial Market Volatility Risk | OLYMPUS CORPORATION (7733) | Komori